In vitro glutaminase regulation and mechanisms of glutamate generation in HIV-1-infected macrophage

Nathan Erdmann, Changhai Tian, Yunlong Huang, Jianxing Zhao, Shelley Herek, Norman Curthoys, Jialin C Zheng

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Mononuclear phagocyte (MP, macrophages and microglia) dysfunction plays a significant role in the pathogenesis of HIV-1-associated dementia (HAD) through the production and release of soluble neurotoxic factors including glutamate. Glutamate production is greatly increased following HIV-1 infection of cultured MP, a process dependent upon the glutamate-generating enzyme glutaminase. Glutaminase inhibition was previously found to significantly decrease macrophage-mediated neurotoxicity. Potential mechanisms of glutaminase-mediated excitotoxicity including enzyme up-regulation, increased enzyme activity and glutaminase localization were investigated in this report. RNA and protein analysis of HIV-infected human primary macrophage revealed up-regulation of the glutaminase isoform GAC, yet identified no changes in the kidney-type glutaminase isoform over the course of infection. Glutaminase is a mitochondrial protein, but was found to be released into the cytosol and extracellular space following infection. This released enzyme is capable of rapidly converting the abundant extracellular amino acid glutamine into excitotoxic levels of glutamate in an energetically favorable process. These findings support glutaminase as a potential component of the HAD pathogenic process and identify a possible therapeutic avenue for the treatment of neuroinflammatory states such as HAD.

Original languageEnglish (US)
Pages (from-to)551-561
Number of pages11
JournalJournal of Neurochemistry
Volume109
Issue number2
DOIs
StatePublished - Apr 1 2009

Fingerprint

Glutaminase
Macrophages
HIV-1
Glutamic Acid
Dementia
Enzymes
Protein Isoforms
Up-Regulation
Human Immunodeficiency Virus Proteins
In Vitro Techniques
Mitochondrial Proteins
Extracellular Space
Enzyme activity
Microglia
Phagocytes
Infection
Glutamine
Cytosol
HIV Infections
RNA

Keywords

  • Glutamate
  • Glutaminase
  • Human immunodeficiency virus-1-associated dementia
  • Macrophages

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

In vitro glutaminase regulation and mechanisms of glutamate generation in HIV-1-infected macrophage. / Erdmann, Nathan; Tian, Changhai; Huang, Yunlong; Zhao, Jianxing; Herek, Shelley; Curthoys, Norman; Zheng, Jialin C.

In: Journal of Neurochemistry, Vol. 109, No. 2, 01.04.2009, p. 551-561.

Research output: Contribution to journalArticle

@article{4e4de56503364c99a5ce6a09c10f3a32,
title = "In vitro glutaminase regulation and mechanisms of glutamate generation in HIV-1-infected macrophage",
abstract = "Mononuclear phagocyte (MP, macrophages and microglia) dysfunction plays a significant role in the pathogenesis of HIV-1-associated dementia (HAD) through the production and release of soluble neurotoxic factors including glutamate. Glutamate production is greatly increased following HIV-1 infection of cultured MP, a process dependent upon the glutamate-generating enzyme glutaminase. Glutaminase inhibition was previously found to significantly decrease macrophage-mediated neurotoxicity. Potential mechanisms of glutaminase-mediated excitotoxicity including enzyme up-regulation, increased enzyme activity and glutaminase localization were investigated in this report. RNA and protein analysis of HIV-infected human primary macrophage revealed up-regulation of the glutaminase isoform GAC, yet identified no changes in the kidney-type glutaminase isoform over the course of infection. Glutaminase is a mitochondrial protein, but was found to be released into the cytosol and extracellular space following infection. This released enzyme is capable of rapidly converting the abundant extracellular amino acid glutamine into excitotoxic levels of glutamate in an energetically favorable process. These findings support glutaminase as a potential component of the HAD pathogenic process and identify a possible therapeutic avenue for the treatment of neuroinflammatory states such as HAD.",
keywords = "Glutamate, Glutaminase, Human immunodeficiency virus-1-associated dementia, Macrophages",
author = "Nathan Erdmann and Changhai Tian and Yunlong Huang and Jianxing Zhao and Shelley Herek and Norman Curthoys and Zheng, {Jialin C}",
year = "2009",
month = "4",
day = "1",
doi = "10.1111/j.1471-4159.2009.05989.x",
language = "English (US)",
volume = "109",
pages = "551--561",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - In vitro glutaminase regulation and mechanisms of glutamate generation in HIV-1-infected macrophage

AU - Erdmann, Nathan

AU - Tian, Changhai

AU - Huang, Yunlong

AU - Zhao, Jianxing

AU - Herek, Shelley

AU - Curthoys, Norman

AU - Zheng, Jialin C

PY - 2009/4/1

Y1 - 2009/4/1

N2 - Mononuclear phagocyte (MP, macrophages and microglia) dysfunction plays a significant role in the pathogenesis of HIV-1-associated dementia (HAD) through the production and release of soluble neurotoxic factors including glutamate. Glutamate production is greatly increased following HIV-1 infection of cultured MP, a process dependent upon the glutamate-generating enzyme glutaminase. Glutaminase inhibition was previously found to significantly decrease macrophage-mediated neurotoxicity. Potential mechanisms of glutaminase-mediated excitotoxicity including enzyme up-regulation, increased enzyme activity and glutaminase localization were investigated in this report. RNA and protein analysis of HIV-infected human primary macrophage revealed up-regulation of the glutaminase isoform GAC, yet identified no changes in the kidney-type glutaminase isoform over the course of infection. Glutaminase is a mitochondrial protein, but was found to be released into the cytosol and extracellular space following infection. This released enzyme is capable of rapidly converting the abundant extracellular amino acid glutamine into excitotoxic levels of glutamate in an energetically favorable process. These findings support glutaminase as a potential component of the HAD pathogenic process and identify a possible therapeutic avenue for the treatment of neuroinflammatory states such as HAD.

AB - Mononuclear phagocyte (MP, macrophages and microglia) dysfunction plays a significant role in the pathogenesis of HIV-1-associated dementia (HAD) through the production and release of soluble neurotoxic factors including glutamate. Glutamate production is greatly increased following HIV-1 infection of cultured MP, a process dependent upon the glutamate-generating enzyme glutaminase. Glutaminase inhibition was previously found to significantly decrease macrophage-mediated neurotoxicity. Potential mechanisms of glutaminase-mediated excitotoxicity including enzyme up-regulation, increased enzyme activity and glutaminase localization were investigated in this report. RNA and protein analysis of HIV-infected human primary macrophage revealed up-regulation of the glutaminase isoform GAC, yet identified no changes in the kidney-type glutaminase isoform over the course of infection. Glutaminase is a mitochondrial protein, but was found to be released into the cytosol and extracellular space following infection. This released enzyme is capable of rapidly converting the abundant extracellular amino acid glutamine into excitotoxic levels of glutamate in an energetically favorable process. These findings support glutaminase as a potential component of the HAD pathogenic process and identify a possible therapeutic avenue for the treatment of neuroinflammatory states such as HAD.

KW - Glutamate

KW - Glutaminase

KW - Human immunodeficiency virus-1-associated dementia

KW - Macrophages

UR - http://www.scopus.com/inward/record.url?scp=62649144579&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62649144579&partnerID=8YFLogxK

U2 - 10.1111/j.1471-4159.2009.05989.x

DO - 10.1111/j.1471-4159.2009.05989.x

M3 - Article

C2 - 19222703

AN - SCOPUS:62649144579

VL - 109

SP - 551

EP - 561

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 2

ER -